Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +11 vs. previous quarter
- 60
- 13F valueReported value at the end of Q2 2026
- $133.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding EQ, Q2 2026
No superinvestor reported holding EQ at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Equillium, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 5 | Same day | Zedelmayer ChristineSr. Vice President and COO | SSale | −14.6K | $2.93 | −$42.7K | −18.9%62.6K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4-5 | 1 day | Connelly StephenPresident and CSO | SSale | −231.0K | $3.13 | −$723.1K | −23.3%762.0K after | 2 lots |
| May 29, 2026 (view filing) | May 28 | 1 day | Tom PennyPrincipal Accounting Officer | SSale | −65.0K | $2.95 | −$191.8K | −100.0%0 after | 10b5-1 |
| May 29, 2026 (view filing) | May 27-28 | 2 days | Zedelmayer ChristineSr. Vice President and COO | SSale | −95.8K | $2.79 | −$267.2K | −60.5%62.6K after | 4 lots10b5-1 |
| Mar 16, 2026 (view filing) | Mar 13 | 3 days | Zedelmayer ChristineSr. Vice President and COO | SSale | −120.3K | $2.50 | −$300.8K | −65.8%62.6K after | 10b5-1 |
| Mar 11, 2026 (view filing) | Feb 19 | 20 days | Zedelmayer ChristineSr. Vice President and COO | SSale | −185.9K | $1.76 | −$327.9K | −67.0%91.4K after | Amended2 lots10b5-1 |
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Zedelmayer ChristineSr. Vice President and COO | SSale | −181.2K | $2.00 | −$362.4K | −74.3%62.6K after | 10b5-1 |
| Jan 9, 2026 (view filing) | Jan 8 | 1 day | Tom PennyPrincipal Accounting Officer | SSale | −6.53K | $1.29 | −$8.43K | −100.0%0 after | 10b5-1 |
| Dec 23, 2025 (view filing) | Dec 23 | Same day | Zedelmayer ChristineSr. Vice President and COO | SSale | −100.0K | $1.50 | −$150.0K | −52.2%91.4K after | 10b5-1 |
| Dec 15, 2025 (view filing) | Dec 12-15 | 3 days | Zedelmayer ChristineSr. Vice President and COO | SSale | −35.7K | $1.33 | −$47.5K | −28.1%91.4K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Equillium, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 6,494,571 | $20.7M | 0.01% | +6,494,571 | New |
| Decheng Capital LLC | 4,447,308 | $14.2M | 1.94% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 4,100,000 | $13.1M | 0.64% | +2,873,690+234.3% | Added |
| ADAR1 Capital Management, LLC | 3,758,569 | $12.0M | 0.57% | +31,910+0.9% | Added |
| Standard Life Aberdeen plc | 3,631,659 | $11.6M | 0.02% | +278,822+8.3% | Added |
| Woodline Partners LP | 3,500,901 | $11.2M | 0.03% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,096,336 | $9.91M | 0.09% | 00.0% | Unchanged |
| StemPoint Capital LP | 2,016,607 | $6.45M | 1.12% | +2,016,607 | New |
| Vanguard Capital Management LLC | 1,822,812 | $5.83M | 0.00% | +38,340+2.1% | Added |
| Eversept Partners, LP | 1,520,824 | $4.87M | 0.27% | +21,831+1.5% | Added |